IRIS
CLEMENTI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.330
NA - Nord America 2.016
EU - Europa 1.381
SA - Sud America 631
AF - Africa 58
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.912
SG - Singapore 894
CN - Cina 741
BR - Brasile 529
IT - Italia 379
SE - Svezia 375
HK - Hong Kong 305
VN - Vietnam 179
DE - Germania 173
RU - Federazione Russa 110
FI - Finlandia 79
GB - Regno Unito 64
CA - Canada 60
AR - Argentina 45
PL - Polonia 38
IN - India 36
FR - Francia 34
JP - Giappone 34
MX - Messico 34
AT - Austria 31
ZA - Sudafrica 29
BD - Bangladesh 25
NL - Olanda 24
EC - Ecuador 22
ES - Italia 19
TR - Turchia 19
IQ - Iraq 17
IE - Irlanda 16
ID - Indonesia 14
UZ - Uzbekistan 12
LT - Lituania 10
EG - Egitto 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
SA - Arabia Saudita 8
PY - Paraguay 7
MA - Marocco 6
PH - Filippine 6
PK - Pakistan 6
UA - Ucraina 6
UY - Uruguay 6
AU - Australia 5
CL - Cile 5
RS - Serbia 5
CH - Svizzera 4
JO - Giordania 4
KZ - Kazakistan 4
RO - Romania 4
VE - Venezuela 4
CM - Camerun 3
IR - Iran 3
PA - Panama 3
PE - Perù 3
TN - Tunisia 3
A1 - Anonimo 2
AZ - Azerbaigian 2
BE - Belgio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
NI - Nicaragua 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GY - Guiana 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
ME - Montenegro 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 6.425
Salva come PNG Salva come JPEG
Città #
Dallas 524
Singapore 437
Hong Kong 302
Ashburn 291
Shanghai 185
Milan 180
Beijing 150
Hefei 117
New York 113
Princeton 81
Lawrence 78
Los Angeles 72
Ho Chi Minh City 70
São Paulo 61
Munich 59
Helsinki 46
Moscow 42
Hanoi 37
Nuremberg 35
Warsaw 33
Tokyo 31
Rome 29
Stockholm 28
Santa Clara 26
Boardman 22
Denver 22
Falkenstein 22
Montreal 22
Brescia 21
London 20
Brooklyn 19
Johannesburg 19
Turku 18
Guangzhou 17
Poplar 17
The Dalles 17
Cesano Boscone 16
Dublin 16
Atlanta 15
Boston 15
Chennai 15
Frankfurt am Main 14
Lappeenranta 14
Orem 14
Toronto 14
Vienna 14
Shenzhen 13
Rio de Janeiro 12
Turin 12
Washington 12
Amsterdam 11
Columbus 11
Houston 11
Seattle 11
Tashkent 11
Belo Horizonte 10
Haiphong 10
Mexico City 10
Ankara 9
Biên Hòa 9
Chicago 9
San Francisco 9
Tianjin 9
Brasília 8
Campinas 8
Hangzhou 8
Porto Alegre 8
Querétaro 8
Salvador 8
Bologna 7
Curitiba 7
Duhok 7
Assago 6
Cape Town 6
Catania 6
Council Bluffs 6
Florianópolis 6
Giza 6
Phoenix 6
Pune 6
Verona 6
Boca 5
Calgary 5
Caxias do Sul 5
City of London 5
Guarulhos 5
Guayaquil 5
Jeddah 5
Jiaxing 5
Manaus 5
Mumbai 5
Quito 5
Taubaté 5
Vancouver 5
Xi'an 5
Amman 4
Ancona 4
Bauru 4
Belgrade 4
Bogotá 4
Totale 3.802
Salva come PNG Salva come JPEG
Nome #
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 148
The interferon landscape along the respiratory tract impacts the severity of COVID-19 100
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 98
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 95
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 92
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 91
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 90
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 90
Answer to Photo Quiz: Scolecobasidium sp 90
Beauveria bassiana Keratitis: A Case Series and Review of Literature 89
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 88
A Biologically-validated HCV E1E2 Heterodimer Structural Model 86
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 85
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 85
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 84
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 82
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 80
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 79
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 79
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 77
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 76
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 75
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 75
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 75
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 74
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 72
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 71
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 71
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 71
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 70
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 70
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 70
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 68
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 67
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 67
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 66
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 65
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue 65
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 65
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 65
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 64
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 64
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 64
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 64
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 63
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 63
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 62
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 61
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 61
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 61
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 59
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients 58
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 58
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 58
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 58
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 56
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 55
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 54
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 54
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 53
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 53
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 53
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 53
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia 52
Role and potential therapeutic use of antibodies against herpetic infections 52
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 52
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 51
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 51
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 51
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 51
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 50
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 50
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 50
HCV E2 core structures and mAbs: something is still missing 49
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 49
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 48
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 48
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 48
Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay 46
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 45
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 45
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 45
Type III interferons disrupt the lung epithelial barrier upon viral recognition 45
Inhibiting immunoregulatory amidase NAAA blocks ZIKV maturation in Human Neural Stem Cells 44
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 43
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 43
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 43
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 43
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 42
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 42
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 42
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 41
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 41
Viral Respiratory Pathogens and Lung Injury 41
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 41
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 40
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 39
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 38
Title: Acute respiratory distress in a neutropenic febrile patient after Hematopoietic Cell Transplantation 35
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV) 35
Totale 6.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 3 4 0 6 0 0
2021/2022115 3 7 13 18 12 7 12 6 3 10 6 18
2022/2023643 191 151 74 8 7 82 43 45 24 2 11 5
2023/2024550 17 31 78 72 45 120 23 48 6 19 19 72
2024/20251.955 178 42 48 77 92 176 320 274 263 147 169 169
2025/20263.302 523 523 660 909 628 59 0 0 0 0 0 0
Totale 6.695